Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $135
Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $125 to $135.
Abbott Lays Off Around 400 Employees As COVID-19 Test Demand Evaporates
Abbott Laboratories (NYSE:ABT) has begun laying off hundreds of workers at its diagnostic plants a month after it slashed its…
Abbott Laboratories Sells STARLIMS Informatics Product Suite And Related Business Assets To Francisco Partners; Terms Not Disclosed
Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, today announced that it has signed a definitive agreement to acquire the STARLIMS informatics product suite
Late-Breaking Data Demonstrate Abbott’s FreeStyle® Libre System Supports Health Equity for Millions of Americans Living with Diabetes
Abbott (NYSE:ABT) today announced late-breaking data that showed FreeStyle Libre, the world's leading7 continuous glucose monitoring (CGM) system, can support health equity through access to more
Citius Shows a Promising Future as Share Prices Keep Going up
In a world facing a global pandemic, advancements in the healthcare sector are pivotal, especially with unmet medical needs of different ranges of diseases and at different levels.
Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic
On CNBC's "Mad Money Lightning Round," Jim Cramer said Senseonics Holdings Inc (NYSE: SENS) competes with DexCom, Inc. (NASDAQ:
Why Senseonics Shares Are Rocketing Higher After Hours Thursday
Study results from a glucose monitoring company were reported after market close Thursday.
Abbott Says Has Capacity And Supply To Support Demand For MCS Devices
Abbott (NYSE:ABT) today announced the company has capacity and supply to effectively support the growing demand for mechanical circulatory support (MCS) devices for the effective treatment of advanced heart failure
The Power and Precision of BioSig’s PURE EP™ System in the Electrophysiology (EP) Market
Arrhythmia, a condition that causes the heart to beat with an irregular or abnormal rhythm, is the fourth leading disease in the United States. Untreated or undiagnosed, arrhythmias can increase the risk of severe health complications—including stroke or even death.